Trial Profile
Profile of Depressive Symptoms in Parkinson's Disease (PRODEST-PD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2023
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms PRODEST-PD
- Sponsors Boehringer Ingelheim
- 31 Mar 2014 New trial record
- 13 Nov 2007